Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
McKinsey
Express Scripts
Queensland Health
QuintilesIMS
McKesson
Teva
US Army
Cipla

Generated: May 21, 2018

DrugPatentWatch Database Preview

Betamethasone - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for betamethasone and what is the scope of betamethasone patent protection?

Betamethasone
is the generic ingredient in twenty-four branded drugs marketed by Schering, Merck Sharp Dohme, Luitpold, Parke Davis, Fougera Pharms, Glenmark Generics, Perrigo New York, Taro, Tolmar, Savage Labs, Actavis Mid Atlantic, Pharmaderm, Teva, Teligent Pharma Inc, Alpharma Us Pharms, Fougera Pharms Inc, G And W Labs Inc, Hi-tech Pharmacal, Promius Pharma Llc, Leo Pharma As, Perrigo Israel, Glenmark Pharms, Watson Labs, Perrigo Uk Finco, Riconpharma Llc, Taro Pharm, Mylan Pharms Inc, Roaco, Pharmafair, Sti Pharma Llc, and Teva Pharms, and is included in one hundred and five NDAs. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are sixty-six drug master file entries for betamethasone. There is one tentative approval for this compound.
Summary for betamethasone
Medical Subject Heading (MeSH) Categories for betamethasone
Synonyms for betamethasone
.beta.-Corlan
.beta.-Methasone
.beta.-Methasone alcohol
(11.beta.,16.beta.)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
(11beta,16beta)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
(1R,2S,10S,11S,13S,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-dien-5-one
(1R,2S,10S,11S,13S,14R,15S,17S)-1-FLUORO-14,17-DIHYDROXY-14-(2-HYDROXYACETYL)-2,13,15-TRIMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-5-ONE
(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one
1,4-Pregnadiene-3,20-dione-9alpha-fluoro-16 beta-methyl-11 beta,17alpha,21-triol
1,4-Pregnadiene-3,20-dione-9alpha-fluoro-16 beta-methyl-11beta,17alpha,21-triol
16-.beta.-Methyl-1,4-pregnadiene-9-.alpha.-fluoro-11-.beta.,17-.alpha.,21-triol-3,20-dione
16-beta-Methyl-1,4-pregnadiene-9-alpha-fluoro-11-beta,17-alpha,21-triol-3,20-dione
16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione
20525-EP2272832A1
20525-EP2295409A1
20525-EP2298778A1
20525-EP2308562A2
20525-EP2314585A1
20525-EP2314590A1
20525-EP2371811A2
378-44-9
378-44-9,956901-32-9(XHCl)
378M449
4-08-00-03501 (Beilstein Handbook Reference)
9-.alpha.-Fluoro-11-.beta.,17-.alpha.,21-trihydroxy-16-.beta.-methylpregna-1,4-diene-3,20-dione
9-.alpha.-Fluoro-11-.beta.,17,21-trihydroxy-16-.beta.-methylpregna-1,4-diene-3,20-dione
9-.alpha.-Fluoro-16-.beta.-methyl-1,4-pregnadiene-11-.beta.,17-.alpha.,21-triol-3,20-dione
9-alpha-Fluoro-16-beta-methyl-1,4-pregnadiene-11-beta,17-alpha,21-triol-3,20-dione
9-alpha-Fluoro-16-beta-methylprednisolone
9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione, (11.beta.,16.beta.) #
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-16.beta.-methylprednisolone
9-fluoro-16beta-methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione
9-Fluoro-16beta-methylprednisolone
9.alpha.-Fluoro-16.beta.-methylprednisolone
9842X06Q6M
9alpha-Fluoro-11beta,17alpha,21-trihydroxy-16beta-methyl-1,4-pregnadiene-3,20-dione
9alpha-Fluoro-11beta,17alpha,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione
9alpha-Fluoro-16 beta-methyl-11beta,17alpha, 21-trihydroxy-1,4-pregnadiene-3,20-dione
9alpha-Fluoro-16 beta-methyl-prednisolone
9alpha-Fluoro-16beta-methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
9alpha-Fluoro-16beta-methylprednisolone
AB0012192
AB1009527
AC1L1TT4
ACN-043339
AKOS008901360
AKOS015894863
API0001693
BCP9000393
BCPP000345
BDBM73823
Bebate
Becort
Bedifos
beta-Methasone
beta-Methasone alcohol
Betacorlan
Betacortril
Betadexamethasone
Betafluorene
Betamamallet
Betametasona
Betametasona [INN-Spanish]
Betametasone
Betametasone [DCIT]
Betamethasone (Celestone)
Betamethasone (JP15/USP/INN)
Betamethasone (JP17/USP/INN)
Betamethasone [USAN:BAN:INN:JAN]
Betamethasone [USAN:INN:BAN:JAN]
Betamethasone [USAN:USP:INN:BAN:JAN]
Betamethasone alcohol
Betamethasone Base
Betamethasone cream
Betamethasone Valearate
Betamethasone, >=95.0% (HPLC), pharmaceutical impurity standard
Betamethasone, >=98%
Betamethasone, European Pharmacopoeia (EP) Reference Standard
Betamethasone, meets USP testing specifications
Betamethasone, pharmaceutical secondary standard; traceable to USP, PhEur, and BP
Betamethasone, United States Pharmacopeia (USP) Reference Standard
Betamethasone, VETRANAL(TM), analytical standard
Betamethasonum
Betamethasonum [INN-Latin]
Betamethasonvalerat Mikron
Betamethazone
Betapredol
Betasolon
bethamethasone
Betnelan
Betnovate (TN)
Betsolan
BIDD:PXR0047
BPBio1_000533
BRD-K39188321-001-03-9
BRN 3176546
BSPBio_000483
C06848
C22H29FO5
CAS-378-44-9
CCG-220362
Celestene
Celeston
Celestona
Celestone
Celestone (TN)
Celestone Syrup and Tablets
Celestone, Betadexamethasone, Flubenisolone, Sch-4831, NCS-39470, Betamethasone
Cellestoderm
CHEBI:3077
CHEMBL632
cid_9782
Cidoten
Corticosterone, 1-dehydro-9-fluoro-17-hydroxy-16.beta.-methyl-
Corticosterone, 1-dehydro-9-fluoro-17-hydroxy-16beta-methyl-
CS-1897
D00244
D0CW1P
D0J5MP
D0Y4LP
D1961
DB00443
Desacort-.beta.
Desacort-Beta
Diprosone (TN)
DSSTox_CID_2667
DSSTox_GSID_22667
DSSTox_RID_76681
DTXSID3022667
EBD2157848
EC 206-825-4
EINECS 206-825-4
Flubenisolone
FT-0622922
GTPL7061
HMS1569I05
HMS2096I05
HMS2233I08
Hormezon
HSDB 3015
HY-13570
KS-5302
Lotrisone
Lotrisone (TN)
LS-118466
LT00441022
Luxiqo
Methazon
MFCD00062969
MLS000859943
MLS001066413
MLS001332616
MLS002153244
MolPort-003-845-025
NCGC00091019-08
NCGC00164401-01
NCGC00164401-02
NCGC00164401-03
NCGC00255195-01
NCS-39470
NSC 39470
NSC-39470
NSC39470
PL007867
Prednisolone, 9-fluoro-16.beta.-methyl-
Prednisolone, 9-fluoro-16beta-methyl-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-beta-methyl-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11.beta.,16.beta.)-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11beta,16beta)-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11.beta.,17,21-trihydroxy-16.beta.-methyl-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy-16beta-methyl-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy-16beta-methyl- (8CI)
Pregna-1,4-diene-3,20-dione, 9alpha-fluoro-11beta,17alpha,21-trihydroxy-16beta-methyl-
Prestwick_703
Prestwick0_000362
Prestwick1_000362
Prestwick2_000362
Prestwick3_000362
Rinderon
Rinderon (TN)
Rinderon A
s1500
SCH 4831
SCH-4831
SCHEMBL4565
SMP1_000043
SMR000058601
SPBio_002404
Tox21_112115
Tox21_112115_1
Tox21_301455
UNII-9842X06Q6M
UREBDLICKHMUKA-DVTGEIKXSA-N
Visubeta
W-106509
ZINC3876136
Tentative approvals for BETAMETHASONE
Applicant Application No. Strength Dosage Form
➤ Try a Free Trial➤ Try a Free Trial0.12%FOAM;TOPICAL

US Patents and Regulatory Information for betamethasone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmaderm BETAMETHASONE VALERATE betamethasone valerate OINTMENT;TOPICAL 018864-001 Aug 31, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Mid Atlantic CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; clotrimazole CREAM;TOPICAL 076002-001 Aug 2, 2002 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Schering DIPROLENE betamethasone dipropionate GEL, AUGMENTED;TOPICAL 019408-002 Nov 22, 1991 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmafair BETAMETHASONE VALERATE betamethasone valerate OINTMENT;TOPICAL 070486-001 May 29, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for betamethasone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering CELESTONE betamethasone TABLET;ORAL 012657-003 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Schering CELESTONE betamethasone CREAM;TOPICAL 014762-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme CELESTONE betamethasone SYRUP;ORAL 014215-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Johnson and Johnson
Moodys
US Army
Covington
McKesson
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.